Similar articles

• Downregulation of human telomerase reverse transcriptase through anti-C-myc siRNA in human colon cancer Colo 320 cells.

  Hu X, Yu N, Fu L, Su W, Huang G, Wu Y, Huang H, Huang H. Hu X, et al. Nucleosides Nucleotides Nucleic Acids. 2009;28(1):1-11. doi: 10.1080/15257770802581633. Nucleosides Nucleotides Nucleic Acids. 2009. Retraction in: Nucleosides Nucleotides Nucleic Acids. 2009 Aug;28(8):793. doi: 10.1080/15257770903167118. PMID: 19116866 Retracted.
• Retraction: siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.

  Hao H, Nancai Y, Lei F, Xiong W, Wen S, Guofu H, yanxia W, Hanju H, Qian L, Hong X. Hao H, et al. J Exp Clin Cancer Res. 2009 Jul 16;28(1):101. doi: 10.1186/1756-9966-28-101. J Exp Clin Cancer Res. 2009. PMID: 19607687 Free PMC article. No abstract available.
• Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.

  Lin CP, Liu JD, Chow JM, Liu CR, Liu HE. Lin CP, et al. Anticancer Drugs. 2007 Feb;18(2):161-70. doi: 10.1097/CAD.0b013e3280109424. Anticancer Drugs. 2007. PMID: 17159602
• Depletion of c-Myc inhibits human colon cancer colo 320 cells' growth.

  Hongxing Z, Nancai Y, Wen S, Guofu H, Yanxia W, Hanju H, Qian L, Wei M, Yandong Y, Hao H. Hongxing Z, et al. Cancer Biother Radiopharm. 2008 Apr;23(2):229-37. doi: 10.1089/cbr.2007.0441. Cancer Biother Radiopharm. 2008. PMID: 18454692
• Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.

  Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J. Ducrest AL, et al. Cancer Res. 2001 Oct 15;61(20):7594-602. Cancer Res. 2001. PMID: 11606399